参考文献/References:
[1] Mason KD,Juneja SK,Szer J.The immunophenotype of acute myeloid leukemia: is there a relationship with prognosis?[J].Blood Rev,2006,20(2):71-82.
[2] Valgardsdottir R,Capitania C,Texido G,et al.Direct involvement of CD56 in cytokinc-induced killer-mediated lysis of CD56+ hematopoetic targer cells[J].Exp Hematol,2014,42(12):1013-1021.
[3] 李 倩,李劲高,周茂华,等.白血病细胞CD56抗原表达与急性髓系白血病患者预后的关系[J].吉林大学学报(医学版),2016,42(2):283-289.
Li Q,Li JG,Zhou MH,et al.Relationship between CD56 antigen expression in leukemia cells and prognosis of patients with acute myeloid leukemia[J].Journal of Jilin University(Medicine Edition),2016,42(2):283-289.
[4] 刘铁强,黄 珊,姚 波,等.伴CD4,CD7表达的AML患者免疫表型特点及其分子生物学和细胞遗传学特征[J].中国实验血液学杂志,2016,24(6):1627-1632.
Liu TQ,Huang S,Yao B,et al.Features of immunophenotypes and characteristics of molecular biology and cellular genetics of AML patients with CD4and CD7 expression[J].Journal of Experimental Hematology,2016,24(6):1627-1632.
[5] 吴红红,曹 晖,王亚哲,等.CD7阳性急性髓系白血病骨髓干/祖细胞5个基因表达的研究[J].中国实验血液学杂志,2009,17(2):298-303.
Wu HH,Cao H,Wang YZ,et al.Expression of 5 genes in CD7 positiveacute myeloid leukemia stem/progenitor cells from bone marrow[J].Journal of Experimental Hematolog,2009,17(2):298-303.
[6] 胡晓梅,杨晓红,王洪志,等.急性髓细胞白血病表达CD7抗原的临床意义以及与细胞遗传学的相关性[J].临床血液学杂志,2009,22(1):2-5.
Hu XM,Yang XH,Wang HZ,et al.Clinical significance of CD7 expression in associated with cytogenetics in acute myeloid leukemia[J].Journal of Clinical Hematology,2009,22(1):2-5.
[7] Swerdlow SH,Campo E,Harris NL.WHO classification of tumors of haematopoietic and lymphoid tissues[M].Lyon:IARC Press,2008:149-155.
[8] Dunphy CH,Orton SO,Mantell J,et al.Realative co-ntributions of enzyme cytochemistry and flow cytochemistry and flow cytometric immunophenotyping tothe evaluation of acute myeloid leukemias with amoncytic component and of flowcytometric immunphenotyping to the evaluation of absolute monocytoses[J].Am JClin Pathol,2004,122(6):865-874.
[9] 杨璐璐,刘 欣,李 庆,等.急性髓系白血病免疫分型特点及与疗效相关性分析[J].中国实验血液学杂志,2014,22(1):1-5.
Yang LL,Liu X,Li Q,et al.Immunophenotyping characteristics of AML and their correlation with the curative effects[J].Journal of ExperimentalHematology,2014,22(1):1-5.
[10] 孔令环,韩 梅,肖中平,等.CD7,CD56,CD19在AML预后及MRD监测中意义[J].中国实验诊断学,2013,17(10):1824-1826.
Kong LH,Han M,Xiao ZP,et al.The clinical significance of CD7,CD56,CD19 detection in prognosis of patients with acute myeliod leukemia and monito-ring in minimal residual disease[J].Clin J Lab Diagn,2013,17(10):1824-1826.
[11] Raspadori D,Damiani D,Lenoci M,et al.CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis [J].Leukemia,2001,15(8):1161-1164.
[12] Junca J,Garcia-Caro M,Granada I,et al.Correlation of CD11b and CD56expression in adult acute myeloid leukemia with cytogenetic risk groups and prognosis[J].Ann Hematol,2014,93(9):1483-1489.
[13] Iriyama N,Hatta Y,Takeuchi J,et al.CD56 expression is an independentprognostic factor for relapse in acute myeloid leukemia with t(8:21)[J].Leuk Res,2013,37(9):1021-1026.
[14] 杨林林,甘思林,刘延方,等.CD56+急性单核细胞白血病的临床特征及预后分析[J].中国实验血液学杂志,2013,21(3):596-600.
Yang LL,Gan SL,Liu YF,et al.Clinical characteristics of CD56+patientswith acute monocytis leukemia and their prognostics significance[J].Journalof Experimental Hematology,2013,21(3):596-600.
[15] 郭 睿,沈安俐,王 琰,等.CD56阳性急性髓系白血病患者的免疫表型分析[J]. 中国实验血液学杂志,2015,23(5):1231-1234.
Guo R,Shen AL,Wang Y,et al.Immunophenotypic analysis of patients withCD56+acute myeloid leukemia[J].Journal of Experimental Hematology,2015,23(5):1231-1234.
[16] 许 娜,刘晓力,杜庆锋,等.急性单核细胞白血病CD56,CD11b表达及临床意义[J].南方医科大学学报,2009,29(8):1605-1608.
Xu N,Liu XL,Du QF,et al.CD56 and CD11b antigen expressions in patients with acute monocytic leukemia and the clinical implications[J].Journal of Southern Medical University,2009,29(8):1605-1608.
[17] Kita K,Miwa H,Nakase K,et al.Clinical importance of CD7 expression in acute myeloid leukemia.The Japan cooperative group of leukemia/lymphoma[J].Blood,1993,81(9):2399-2405.
[18] Kerkent W,Chahwan C,Lenormand C,et al.Usefulness of urethral endoprosthesis in the management of urinary retention after brachytherapy for localized prostate cancer[J].Prog Urol,2014,24(3):164-166.
[19] Eto T,Akashi K,Harada M,et al.Biological characteristics of CD7 positive acute myelogenous leukaemia[J].Br J Haematol,1992,82(3):508-514.
[20] 张任群,饶爱华,欧阳桂芳.细胞表面分化抗原CD15在264例成人白血病细胞上的表达[J].上海预防医学杂志,2009,21(9):467-468.
Zhang RQ,Rao AH,Ouyang GF.Expression of cell surface differentiation antigen CD15 on 264 cases of adult leukemia cells[J].Shanghai Journal ofPreventive Medicine,2009,21(9):467-468.
[21] Huiwitz CA,Rainondi SC,Head D.et al.Distinctive immunophenotypic features of t(8; 21)(q22; q22)acute myeloblastic leukemia in children[J].Blood,1992,80(12):3182-3188.
[22] 张婧婧,张 楠,李 光,等.急性髓系白血病98例免疫表型特征及其临床意义[J].实用儿科临床杂志,2011,26(15):1190-1191.
Zhang JJ,Zhang N,Li G,et al.Characteristics and clinical significanceof immunophenotyping in 98 children with acute myeloid leukemia[J].J Appl Clin Pediatr,2011,26(15):1190-1191.
相似文献/References:
[1]张灵玲,张朝明,谢国丽.中性粒VCS参数表达的性别差及差异表达的临床应用[J].现代检验医学杂志,2015,30(06):86.[doi:10.3969/j.issn.1671-7414.2015.06.025]
ZHANG Ling-ling,ZHANG Chao-ming,XIE Guo-li.Gender Differences of Neutrophil VCS Parameter Expression
and Clinical Application of Differential Expression[J].Journal of Modern Laboratory Medicine,2015,30(04):86.[doi:10.3969/j.issn.1671-7414.2015.06.025]
[2]范臻佳,金丽兰,史册,等.急性髓系白血病患者外周血粒细胞、单核细胞膜GPI锚链和红细胞表面CD59表达水平的研究[J].现代检验医学杂志,2019,34(01):26.[doi:10.3969/j.issn.1671-7414.2019.01.007]
FAN Zhen-jia,JIN Li-lan,SHI Ce,et al.Expression Level of Peripheral Blood Granulocytes and Monocytes
GPI Anchor Chain and Erythrocyte CD59 in AML Patients[J].Journal of Modern Laboratory Medicine,2019,34(04):26.[doi:10.3969/j.issn.1671-7414.2019.01.007]
[3]李 悦,徐焕铭,樊 华.基于TCGA 数据对60 岁以上不同分层急性髓系白血病患者相关lncRNA 的基因信息学分析[J].现代检验医学杂志,2020,35(03):20.[doi:10.3969/j.issn.1671-7414.2020.03.005]
LI Yue,XU Huan-ming,FAN Hua.Genetic Informatics Analysis of lncRNA Related to Patients with Different
Stratified Acute Myeloid Leukemia Over 60 Years Based on TCGA Database[J].Journal of Modern Laboratory Medicine,2020,35(04):20.[doi:10.3969/j.issn.1671-7414.2020.03.005]
[4]张梦娜,李文生.髓过氧化物酶在淋巴造血系统疾病表达的最新研究进展[J].现代检验医学杂志,2022,37(02):195.[doi:10.3969/j.issn.1671-7414.2022.02.039]
ZHANG Meng-na,LI Wen-sheng.Recent Research Progress of Myeloperoxidase Expression in Lymphatic Hematopoietic Diseases[J].Journal of Modern Laboratory Medicine,2022,37(04):195.[doi:10.3969/j.issn.1671-7414.2022.02.039]
[5]萧杏贤,刘 德,姜朝晖.AML不同疾病阶段患者T细胞耗竭及相关细胞因子表达水平实验研究[J].现代检验医学杂志,2022,37(03):138.[doi:10.3969/j.issn.1671-7414.2022.03.029]
XIAO Xing-xian,LIU De,JIANG Zhao-hui.Experimental Study on T Cell Exhaustion and Related Cytokine Expression Levels in Patients with AML at Different Disease Stages[J].Journal of Modern Laboratory Medicine,2022,37(04):138.[doi:10.3969/j.issn.1671-7414.2022.03.029]
[6]刘 睿,王玉明.竞争性内源性RNA在急性髓系白血病中的研究进展[J].现代检验医学杂志,2022,37(03):198.[doi:10.3969/j.issn.1671-7414.2022.03.041]
LIU Rui,WANG Yuming.Research Progress of Competitive Endogenous RNA in Acute Myeloid Leukemia[J].Journal of Modern Laboratory Medicine,2022,37(04):198.[doi:10.3969/j.issn.1671-7414.2022.03.041]
[7]罗 婷,段蕴枭,钟 浩,等.急性髓系白血病患者血清miR-24，miR-106a 水平表达及其临床诊断价值[J].现代检验医学杂志,2024,39(05):1.[doi:10.3969/j.issn.1671-7414.2024.05.001]
LUO Ting,DUAN Yunxiao,ZHONG Hao,et al.Expression of Serum miR-24 and miR-106a Levels in Patients with Acute Myeloid Leukemia and Its Clinical Diagnostic Value[J].Journal of Modern Laboratory Medicine,2024,39(04):1.[doi:10.3969/j.issn.1671-7414.2024.05.001]